Hearing Loss Clinical Trials in Atlanta, Georgia
2 recruitingAtlanta, Georgia
Showing 1–2 of 2 trials
Recruiting
Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Head and Neck CancerHearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)224 enrolled5 locationsNCT04915183
Recruiting
The Sentio System: Post-market Evaluation of Safety and Performance in Adolescents
Hearing Loss
Oticon Medical25 enrolled1 locationNCT06844071